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According to Diabetes Atlas – fourth edition, published by
International Diabetes Federation (IDF), India alone will
have 50.8 million people with diabetes in 2010. India is a fast
growing economy, and has diverse population, with varying
levels of literacy, income, traditional and cultural beliefs
and varieties of diet pattern. With the current epidemiological
transition, the disease pattern shows evidence of shift from
communicable to non-communicable diseases, which is more
signiﬁcant in the urban areas [1]. The prevalence of diabetes
is high in urbanized society, and the reported prevalence of
diabetes in rural India varies from 3.6% to 12.5% [2]. Thus,
a profound burden is placed on the healthcare system to
manage diabetes mellitus and its complications. The health-
26 S. Tharkar et al.care sector is mostly privatized in India, and most people pre-
fer the private to public health sector [3].
At the onset, it is essential to determine the practices
adopted during diabetes care at all levels, both on the part
of the government and in the private sector. We hypothesize
that the recommended guidelines for diabetes service delivery
are not standardized and are not being implemented uniformly
at all levels of healthcare in a country that has the highest
number of people with diabetes, namely India. Very little re-
search has been conducted in India to study the quality of dia-
betes care and management across different health settings [4].
Hence, it is necessary to study and determine the pattern of
diabetes service delivery in this country, the main aim of this
study. This paper determines the healthcare delivery of diabe-
tes in terms of patients’ proﬁles, investigations, patterns of pre-
scription of drugs and economics of diabetes care under three
different settings. The paper may serve as an evidence-based
document to highlight the need for improved diabetes care
and to implement the standard of care at all levels that the pa-
tient deserves.2. Methods
The study used a cross sectional design (house to house survey)
with a multistage cluster random sampling technique from the
zones which were selected based on the directions – north,
south, east and west, to obtain a representative sample. With
the prevalence of diabetes as 19%, 80% power, .05 level of sig-
niﬁcance and a precision of six, the sample size required was
168. Patients with diabetes who had taken treatment for diabe-
tes from any health center, and those who had maintained hos-
pital records, were considered for further data collection. Data
were collected using a questionnaire developed by epidemiolo-
gists, which was pilot tested, with suitable modiﬁcations being
incorporated. The questionnaire was administered by trained
research ofﬁcers in the ﬁeld of diabetes epidemiology, with
each interview lasting for approximately 45 min. The question-
naire incorporated, section by section, details regarding soci-
odemographic characteristics, place of diabetes care, the
investigation details, types of drugs prescribed and taken,
any history of diabetes complications, counseling methods
and cost patterns. The entire data were then categorized into
three groups, as described above, and the statistics were com-
puted and compared for the parameters under study, using
SPSS version 10.0. Percentages have been reported for the cat-
egorical variables, and student t-test, z-test and median tests
were conducted to obtain statistical differences wherever
applicable.3. Results
The study population comprised 180 patients, who responded
well to the interview. The distribution of patients attending the
health centers was as follows; Group I: Diabetes Specialty
Centres – 83 patients, Group II: Private Clinics – 82 patients,
and Group III: those visiting Government Hospitals – 15 pa-
tients. The patient characteristics and the socio-demographic
proﬁle are described in Table 1, for the three groups with the
denominator taken as per the size of the listed variable. The
age and gender distribution of the study sample were similar
in Group I and II. Most patients seeking treatment from thegovernment centers belonged to the ﬁrst income tertile, while
there were none from the highest income group visiting the
government centers. Increase in income was directly propor-
tional to the increase in the number of patients visiting diabe-
tes specialty centers, while it was inversely proportional to
private clinics. Those patients who had attained higher educa-
tion and those in white collar jobs preferred private treatment.
As the chronic nature of the disease increased, patients
opted to seek treatment from specialized centers. The distribu-
tion of patients with less than 5 years duration of diabetes was
as follows; Group I – 31%, Group II – 56.3% and Group III –
12.7%. An increase in the duration of diabetes showed a signif-
icant increase and shift toward specialty centers: for instance,
for greater than 10 years duration, the ﬁgures were 60.3%,
34.9%, and 4.8% for Group I, II, and III, respectively.
The HbA1c test was not prescribed at the government cen-
ters, while only 31.7% and 6.1% of Group I and II had it
checked. Among them, Group I patients seem to have a better
control of diabetes, compared to Group II (p= 0.031), as
their mean HbA1c was comparatively lower. Other investiga-
tions, such as retinal examinations, foot examinations and car-
diac checkups were conducted only among 28% and 21.7% of
Group I and II patients, while the investigations were never
prescribed during routine visits in government centres. The
estimation of blood through fasting and post prandial method
was the only test prescribed at government centres. The prac-
tice of self monitoring of glucose (SMBG) was observed
among 26.8% and 10.8% of the Group I and II patients,
respectively. Professional advice and counseling regarding
healthy lifestyle-like diet modiﬁcation and physical activity
methods was given only at specialized diabetes centers. Group
II and III patients had never been counseled, or advised on
lifestyle modiﬁcation during routine visits (Table 2).
Around 59% of the study sample had developed at least
one complication related to diabetes. Table 3 shows the distri-
bution of patients according to the complication. Diabetes pa-
tients who develop complications preferred treatment at a
diabetes specialty center, but the differences across the groups
did not reach statistically signiﬁcance levels.
The pattern of drug prescription varied across the three
groups described in Table 4. Sulphonylureas and/or biguanides
were the basic drug in all prescriptions across the overall sam-
ple. In addition to this, compounds like thiazolidinediones and
a-glucosidase inhibitors and DPP4 inhibitors were prescribed
in Group I and II patients. Around 16% of the patients used
insulin, of whom 13.5% were from Group I and 2.7% from
Group II. Surprisingly none of the patients attending govern-
ment centers were on insulin. Similarly cardio protective med-
ication, such as statins and anticoagulants were commonly
used at specialized centers (17.6%) and its use declined to
4.1%, at private clinics and to 1% at government centers.
The socioeconomics related to diabetes care in the commu-
nity is illustrated in Table 5 in terms of direct, indirect and
intangible costs. The per annum direct cost, which includes
consultation fees, investigations and medication cost, was sig-
niﬁcantly higher for Group I – 16,200 INR than Group II –
9450 INR. Indirect cost which calculated the loss in income
was also higher for Group I, but never reached statistical sig-
niﬁcance. The bidding method to determine intangible costs
was based on how much money the patients were willing to
spend every month to prevent future problems, was again sig-
niﬁcantly higher in Group I.
Table 1 Socio-demographic proﬁle.
Socio-demographic details Diabetes specialty centers (I) Private clinics (II) Government hospital (III)
Total sample N
N= 180 82 (45.6) 83 (46.1) 15 (8.3)
Age in years
<50 20 (48.8) 19 (46.3) 2 (4.9)
P50 62 (44.6) 64 (46.0) 13 (9.4)
Gender (M:F; 78:102)
Male 39 (50.0) 36 (46.2) 3 (3.8)
Female 43 (42.2) 47 (46.0) 12 (11.8)
Education
Illiterate 3 (1.7) 6 (3.3) 5 (2.8)
School 44 (24.4) 48 (26.7) 10 (5.6)
Graduation and above 35 (19.4) 29 (16.1) –
Occupation
Skilled/unskilled 7 (3.9) 11 (6.1) 3 (1.7)
Executive/professional 11 (6.1) 12 (6.6) –
Business 15 (8.3) 8 (4.4) 1 (0.6)
Retired/H.W/unemployed 49 (27.2) 52 (28.9) 11 (6.1)
Income per month in INR
<10,000 15 (24.6) 34 (55.7) 12 (19.7)
10,001–30,000 32 (49.2) 30 (46.1) 3 (4.6)
30,001 & above 35 (64.8) 19 (35.2) –
Duration of diabetes in years
65 22 (31) 40 (56.3) 9 (12.7)
5.1–10 22 (47.8) 21 (45.7) 3 (6.5)
P10.1 38 (60.3) 22 (34.9) 3 (4.8)
Complications
Nil 23 (12.8) 44 (24.4) 7 (3.9)
One 27 (15.0) 13 (7.2) 5 (2.8)
Two 20 (11.1) 17 (9.4) 2 (1.1)
Three 10 (5.6) 9 (5.0) –
Four & above 2 (1.1) – 1 (0.6)
The percentages have been derived across the row or for the listed variable on the whole whichever is applicable.
Table 2 Comparison of the basic and other investigations.
Basic investigations Group I Group II Group III
Hba1c (mean) 8.2 ± 0.3* 10.2 ± 0.6* –
Random 7 (8.5) 13 (15.7) –
Fasting/post prandial 73 (89) 63 (76)a 15 (100)b,c
Hba1c test done 26 (31.7) 5 (6.1)a –
Other investigations (ECG, echo, doppler, retinal examination etc.) 23 (28) 18 (21.7) –
Self monitoring of blood glucose 22 (26.8) 9 (10.8)a –
a – I vs II, b – I vs III, c – II vs III.
a,b,c Z-test p-value < 0.05 statistically signiﬁcant.
* t-test p-value = 0.031 statistically signiﬁcant.
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The challenge in diabetes care and management in India is set
to become still tougher, due to rising prevalence rates of diabe-
tes. The health care system in India broadly consists of two
categories – governmental and private. The private health sec-
tor is clustered around urban areas, and consists of all types of
private hospitals and family clinics. The government system
operates through medical institutions and tertiary care centersin urban areas and as primary health centers and district hos-
pitals which largely dominate in rural areas.
This study has important ﬁndings from two points of view –
the treatment seeking behavior of diabetes patients in the com-
munity and the type of diabetes care delivery at various health
care systems. We found that only 8% of the study population
visited government hospitals, which was in agreement with the
ﬁndings from other reports and studies [5]. The low income
group, those with lesser duration of diabetes and those with
Table 3 Prevalence of complications across 3 groups.
Prevalence of complications (total) Group I Group II Group III
Retinopathy (18.3) 11 (6.1) 17 (9.4) 5 (2.8)
Nephropathy (6.1) 10 (5.6) 1 (0.6) –
Neuropathy (16.7) 17 (9.4) 11 (6.1) 2 (1.1)
Foot complications (23.9) 22 (12.2) 17 (9.4) 4 (2.2)
Cardiac complications (18.9) 18 (10) 14 (7.8) 2 (1.1)
Hyperglycemia (11.1) 13 (7.2) 7 (3.9) –
Hypoglycemia (5.6) 7 (3.9) 2 (1.1) 1 (0.6)
Hypertension (31.7) 30 (16.7) 24 (13.3) 3 (1.7)
Table 4 Diabetes Drug prescription among three different health care set up.
Drugs Total (%)
N= 74
Group I N (%)
N= 36
Group II N (%)
N= 23
Group III N (%)
N= 15
Sulfonylureas/biguanides 73 (98.6) 9 (12.2) 10 (13.5) 11 (14.9)
Sulfonylureas/biguanides with combination 26 (35.1) 13 (17.6) 4 (5.4)
Thiazolidinediones 6 (8.3) 1 (1.4) 3 (4.1) 2 (2.7)
Inhibitors
AGI/DPP – IV 11 (15) 8 (10.8) 3 (4.1) –
Insulin 12 (16.2) 10 (13.5) 2 (2.7) –
Statin/Anticoagulants 17 (22.9) 13 (17.6) 3 (4.1) 1 (1.4)
Antihypertensives 27 (36.5) 17 (23.0) 9 (12.2) 1 (1.4)
Table 5 Economics of diabetes care.
Diabetes specialty centers (I) Private clinics (II) Government hospitals (III) p-value
No. of hospitalization per annum 2 1 1 –
No. of op visits 4 4 12 –
Direct cost INR per annum 16,200 9450 18 0.000#
Indirect cost INR per annum 3000 1500 – 0.5
Intangible cost INR per annum 2000 1000 500 0.000#
# Median test p-value < 0.05 statistically signiﬁcant.
S. Tharkar et al.28nil complications are the type of patients who sought diabetes
care from small private clinics and government set up. It was
also observed that with a gradual increase in the duration of
diabetes, and with the development of complications, patients
preferred to seek treatment from specialized diabetes centers.
These results serve as initial evidence for the sub-standard care
offered at various levels.
Evidence from the research suggests that maintaining opti-
mum glycemic levels may delay the onset of complications and
prevent premature mortality [6]. ADA and EASD have
brought out consensus and guidelines to achieve the goals in
diabetes management [7]. With the effective implementation
of these guidelines in various programmes, they succeeded in
lowering both morbidity and mortality rates. Pertaining to
the needs of our country, the excerpts from them were re-
framed and published in 2002, with a strong focus on compre-
hensive diabetes care [8]. ICMR guidelines for management of
type 2 diabetes, framed in 2005, emphasize the same [9]. The
IDF Clinical Guidelines Task Force has established global
guidelines for type 2 diabetes, based on the availability and
affordability of resources in the countries, broadly under three
levels of care – standard care, comprehensive care and minimal
care [10]. Our results document some of the important draw-backs in terms of the quality of diabetes care, from the point
of view of clinical monitoring, self monitoring, screening for
complications, education, lifestyle management, etc, indicating
a direct deviation from these guidelines. For instance, adher-
ence to HbA1c testing was nil in government centers and neg-
ligible in private clinics. Even among specialized diabetes
centers, only 31% recommended HbA1c tests, where similar
results were shown in other studies [11]. When A1c assay is rec-
ommended and considered as a diagnostic test for type 2 dia-
betes, besides clinical monitoring, our study on the other hand
has reported the underutilization of A1c tests, even during rou-
tine visits. With the availability of many national and interna-
tional guidelines, the study observed a gross deviation in its
implementation during clinical practice.
Another issue of concern is the inappropriate screening for
other complications during routine visits. Despite claims of
regular screening for retinal, renal, cardiac and foot complica-
tions, this screening was seen as less than adequate even among
specialized centers and private clinics and was never practiced
at government centers. The late detection of complications im-
poses an enormous burden on the patients in terms of econom-
ics, psychosocial issues, morbidity and even early mortality. If
cost and resources are deﬁcient, simple cost effective proce-
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such as detecting microalbuminuria for nephropathy, monoﬁl-
ament test for peripheral neuropathy, etc, as per IDF guide-
lines, for minimal care.
Self monitoring of blood glucose leads to better glycemic
control and delay in development of complications [12], but
it was important to note that in this study, it was neither ad-
vised nor practiced among the patients attending the govern-
ment centers, while even the specialty centers showed poor
prevalence of practices of self monitoring of blood glucose.
These results are similar to the DiabCare Asia – India study,
which has also found a low frequency of self monitoring
[13]. The effective management of diabetes is a combination
of medication and lifestyle change. A further important ﬁnding
was the absence of educative and interactive sessions on diabe-
tes management during the review visits. Education on lifestyle
modiﬁcation and patient counseling was never conducted ex-
cept in some specialty centers. These results showed a total
lack of patient education during diabetes service delivery,
which is considered vital in terms of effective glycemic control
and good long term health devoid of complications. These
ﬁndings provide additional evidence for substandard practices
and lack of comprehensive diabetes care.
The specialized centers generally gave more comprehensive
prescriptions, featuring insulin or OHAs, along with cardio
protective drugs. The government health centers, on a routine
basis, prescribed only biguanides and sulphonylureas irrespec-
tive of the level of glycemic control and the duration of diabe-
tes. Even though insulin was available free of charge, none of
our study patients from government centers were on insulin,
probably due to two primary reasons identiﬁed during inter-
view process – lack of availability of insulin and the lack of
trained staff to teach about the methods of injection practices
and poor facilities for storage and maintenance (data not
shown). These ﬁndings are supported by evidence from other
published reports from the WHO [14] and a rural study [15].
In addition to this, in the absence of national reforms and
insurance policies, the problem seems to be further exacer-
bated, as evidence shows the increased cost of diabetes man-
agement and poor affordability of patients in meeting their
expenses, thereby indirectly affecting metabolic control, as dis-
cussed elsewhere [16].
The public health system in India is successful in preventing
and managing certain communicable diseases, such as leprosy,
HIV–AIDS and in resourcing programmes, such as the immu-
nization and maternal child health programmes [17]. However,
the allocation of programmes for non communicable diseases
is limited. With the launch of National Rural Health Mission
in 2005, and the programmes for prevention and control of
diabetes, cardiovascular diseases and stroke, there has been a
highly commendable focus on non communicable diseases.
In this case, our study might serve to identify the deﬁciencies
in diabetes service delivery, so that planning solutions and
working out strategies may be undertaken and such pro-
grammes may be implemented more effectively.
To conclude, the study reports a wide gap that exists be-
tween the recommended clinical guidelines for diabetes care
and the actual diabetes service delivery. Non adherence to
the recommended guidelines may lead to poorer glycemic con-
trol, with the direct effect of increasing the complications and
deepening the cost burden. These results are a reminder of the
grave dangers in the future arising from the growing preva-lence of diabetes, and they highlight the urgent need to address
the issues.
Clinical monitoring and screening for complications are
essential inasmuch as screening for diabetes and health promo-
tion activities serve to reduce the burden of diabetes in this
country. In addressing issues relating to diabetes prevention,
diabetes care and meeting the cost must be made into a na-
tional health priority. Framing strategies, reorganizing health
care structure and standardizing procedures to better imple-
ment the global guidelines for type 2 diabetes are of utmost
importance. The effectiveness and sustainability of diabetes
service delivery at the government level and among the private
practitioners should be an overall aim, since most of the pop-
ulation is largely dependent on them.Conﬂict of interest
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